Volume 4, Issue 3 (9-2018)                   jhehp 2018, 4(3): 116-120 | Back to browse issues page


XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Kashfi S M, Mohaghegh Sharifi E, Rakhshani T, Hosseini S S. Tests for the Prevention of Thalassemia Major in the Couples Referring to Behbahan Health Center, Iran During 2006-2016. jhehp 2018; 4 (3) :116-120
URL: http://jhehp.zums.ac.ir/article-1-172-en.html
1- Research Center of health science, Department of Public Health, School of Public Health, Shiraz University of Medical Sciences, Shiraz, Iran.
2- MS in Community Education, School of Public Health, Shiraz University of Medical Sciences, Shiraz, Iran.
3- Nutrition Research Center , Department of Public Health, School of Public Health, Shiraz University of Medical Sciences, Shiraz, Iran.
4- Department of Public Health, Behbahan University of Medical Sciences, Behbahan, Iran.
Abstract:   (8209 Views)
Background: Thalassemia is the most prevalent genetic disorder in humans. It is caused by the deficient or lack of production of one of the globin chains. The present study aimed to evaluate the performance indicators of Behbahan Health Center, Iran in terms of the prevention of thalassemia major during 2006-2016.
Methods: This descriptive, cross-sectional study was conducted on the couples referring to the pre-marriage counseling centers in Behbahan, Iran for premarital tests during 2006-2016. The participants were selected via census sampling.
Results: In total, 24,992 couples were screened, 0.33% of whom (n = 84) were suspected of thalassemia. Out of 84 couples, two cases declared marriage cancellation after electrophoresis. The results of the PND1 test indicated that in 96% of the couples (n = 73), the boy and girl both had thalassemia minor, while in 1.3% of the cases (n = 1), one of them had thalassemia minor, and in 6.2% (n = 2), they were both normal.
Conclusion: According to the results, 84 couples were carriers of thalassemia during 2006-2016. Eventually, all the cases with thalassemia major were aborted and prevented from birth.
Full-Text [PDF 564 kb]   (8774 Downloads)    
Type of Study: Original Article | Subject: Public Health
Received: 2018/06/17 | Accepted: 2018/08/20 | Published: 2018/09/21

References
1. Gulbis B, Eleftheriou A, Angastiniotis M, Ball S, Surrallés J, Castella M, et al. Epidemiology of Rare Anaemias in Europe. In Rare Dis Epidemiol, Springer, Dordrecht. 2010: 375-96. [Crossref]
2. Cunningham MJ, Macklin EA, Neufeld EJ, Cohen AR, Network TCR. Complications of β-thalassemia Major in North America. Blood. 2004 ;104(1): 34-9. [Crossref]
3. Tanno T, Bhanu NV, Oneal PA, Goh SH, Staker P, Lee YT, et al. High Levels of GDF15 in Thalassemia Suppress Expression of the Iron Regulatory Protein Hepcidin. Nat Med. 2007; 13(9): 1096. [Crossref]
4. Olivieri NF, Brittenham GM. Iron-Chelating Therapy and the Treatment of Thalassemia. Blood. 1997; 89(3) :739-61.
5. Rezaie Keikha R, Masoudy G, Ramazani A, Shahraki M, Naderi M. The Survey of the Knowledge and Practice of Thalassemia Couples Based on Health Belief Model in Sistan Area . Sci J Iran Blood Transfus Organ. 2016; 12 (4) : 369-77.
6. Vinchi F, Vercellotti GM, Belcher JD, Sparla R, Fibach E, Zreid H, et al. Elevated Systemic Heme and Iron Levels as Risk Factor for Vascular Dysfunction and Atherosclerosis: Evidence from a Beta-Thalassemia Cohort Study. Atherosclerosis. 2017; 263: e107-8. [Crossref]
7. Jafari F, Sharifi N, Zayeri F. Effectiveness of Thalassemia Prevention Program on Increasing the Knowledge of Couples and Abandonment of Marriage in Gorgan. Sci J Gorgan Univ Me Sci. 2007; 8 (4): 68-72.
8. Chow C, Dang T, Guo V, Chow M, Li Q, Chow DTL, et al. Optimization of Unrelated Donor Cord Blood Transplantation for Thalassemia: Implications for Other Non‐Malignant Indications Such as HIV Infection or Autoimmune Diseases. Umbilical Cord Blood Bank Clin Appl Regen Med: InTech. 2017.
9. Hajian KO. Attitude and Knowledge of Couple about Thalassemmia at the Stage of Marriage in Babol. J Guillan Univ Med Sic. 2000; 9, 33-4.
10. Alavi A, Parvin N, Kheiri S, Hamidizade S, Tahmasebi S. Comparison of Perspective of Children with Major Thalassemia and Their Parents about Their Quality of Life in Shahrekord. J Shahrekord Univ Med Sci. 2007; 8 (4) : 35-41.
11. Zeinalian M, Samavat A, Fadayee N, Azin SA. Incidence Rate of Major Beta-Thalassemia and Study of its Causes after Prevention and Control Program of Thalassemia in Isfahan Province. Sci J Iran Blood Transfus Organ. 2009; 6(4): 238-47.
12. Abolghasem A, Eshghi P, RahimiNejad MS, Hatami S. Evaluation and Analysis of Cost-Effectiveness of Thalassemia Diagnosis and Prevention Program in Sistan & Baluchestan Province and Fars Province. Hakim Res J. 2006; 8 (4): 8-14.
13. Kosarian M, Okhovatian BF. To What Extent Have We Succeeded in the Country's Plan to Prevent Major Thalassemia in Mazandaran University of Medical Sciences (1992-2002). J Mazandaran Univ Med Sci. 2003; 13 (41): 47-54.
14. Mehrabian F, Valipour R, Kasmaei P, Atrkar Rohan Z, Mahdavi Roshan M. The Effect of Education on the Basis of the BASNEF Model on Promoting Nutritional Behavior of Prevention of Iron Deficiency Anemia. J Holistic Nurs Midwifery. 2016; 26 (1): 89-98.
15. Eldini Sh. Studying Spirometric Findings of the Patients with Thalassemia Major Referring to Bandar Abbas Children's Hospital and Thalassemia Clinic in 2017. Hormozgan Univ Med Sci; 2017.

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 The Author(s)

© 2025 CC BY-NC 4.0 | Journal of Human Environment and Health Promotion

Designed & Developed by : Yektaweb